Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Tall young females get ahead: size-specific fecundity in wild kangaroos suggests a steep trade-off with growth.

Quesnel L, King WJ, Coulson G, Festa-Bianchet M.

Oecologia. 2018 Jan;186(1):59-71. doi: 10.1007/s00442-017-4003-4. Epub 2017 Nov 10.

PMID:
29127479
2.

Characterization of the Cellular Output of a Point-of-Care Device and the Implications for Addressing Critical Limb Ischemia.

Woodell-May JE, Tan ML, King WJ, Swift MJ, Welch ZR, Murphy MP, McKale JM.

Biores Open Access. 2015 Nov 1;4(1):417-24. doi: 10.1089/biores.2015.0006. eCollection 2015.

3.

Mother-offspring distances reflect sex differences in fine-scale genetic structure of eastern grey kangaroos.

King WJ, Garant D, Festa-Bianchet M.

Ecol Evol. 2015 May;5(10):2084-94. doi: 10.1002/ece3.1498. Epub 2015 Apr 22.

4.

Adoption in eastern grey kangaroos: a consequence of misdirected care?

King WJ, Forsyth DM, Coulson G, Festa-Bianchet M.

PLoS One. 2015 May 13;10(5):e0125182. doi: 10.1371/journal.pone.0125182. eCollection 2015.

5.

Complementary and alternative medicine: a survey of its use in pediatric cardiology.

Adams D, Whidden A, Honkanen M, Dagenais S, Clifford T, Baydala L, King WJ, Vohra S.

CMAJ Open. 2014 Oct 1;2(4):E217-24. doi: 10.9778/cmajo.20130075. eCollection 2014 Oct.

6.

Growth and development in thanatophoric dysplasia - an update 25 years later.

Nikkel SM, Major N, King WJ.

Clin Case Rep. 2013 Dec;1(2):75-8. doi: 10.1002/ccr3.29. Epub 2013 Nov 15.

7.

Patterns of utilization of complementary and alternative medicine in 2 pediatric gastroenterology clinics.

Adams D, Schiffgen M, Kundu A, Dagenais S, Clifford T, Baydala L, King WJ, Vohra S.

J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):334-9. doi: 10.1097/MPG.0000000000000439.

PMID:
24854897
8.

CAM use in pediatric neurology: an exploration of concurrent use with conventional medicine.

Galicia-Connolly E, Adams D, Bateman J, Dagenais S, Clifford T, Baydala L, King WJ, Vohra S.

PLoS One. 2014 Apr 15;9(4):e94078. doi: 10.1371/journal.pone.0094078. eCollection 2014.

9.

Complementary and alternative medicine: A survey of its use in children with chronic respiratory illness.

Richmond E, Adams D, Dagenais S, Clifford T, Baydala L, King WJ, Vohra S.

Can J Respir Ther. 2014 Spring;50(1):27-32.

10.

Top 10 tips for effective use of electronic health records.

Wuerth R, Campbell C, King WJ.

Paediatr Child Health. 2014 Mar;19(3):138. No abstract available.

11.

From bruises to brain injury: The physician's role in the assessment of inflicted traumatic head injury.

Ward MG, King WJ, Bennett S.

Paediatr Child Health. 2013 Oct;18(8):423-4. No abstract available.

12.

Complementary and alternative medicine: a survey of its use in pediatric oncology.

Valji R, Adams D, Dagenais S, Clifford T, Baydala L, King WJ, Vohra S.

Evid Based Complement Alternat Med. 2013;2013:527163. doi: 10.1155/2013/527163. Epub 2013 Nov 6.

13.

Complementary and alternative medicine use by pediatric specialty outpatients.

Adams D, Dagenais S, Clifford T, Baydala L, King WJ, Hervas-Malo M, Moher D, Vohra S.

Pediatrics. 2013 Feb;131(2):225-32. doi: 10.1542/peds.2012-1220. Epub 2013 Jan 14.

PMID:
23319526
14.

Cyclic-RGD peptides increase the adenoviral transduction of human mesenchymal stem cells.

King WJ, Krebsbach PH.

Stem Cells Dev. 2013 Feb 15;22(4):679-86. doi: 10.1089/scd.2012.0379. Epub 2012 Oct 17.

15.

Growth factor delivery: how surface interactions modulate release in vitro and in vivo.

King WJ, Krebsbach PH.

Adv Drug Deliv Rev. 2012 Sep;64(12):1239-56. doi: 10.1016/j.addr.2012.03.004. Epub 2012 Mar 10. Review.

16.

Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications.

King WJ, Kouris NA, Choi S, Ogle BM, Murphy WL.

Cell Tissue Res. 2012 Mar;347(3):689-99. doi: 10.1007/s00441-011-1297-0. Epub 2012 Jan 26.

17.

The helpful or hindering effects of in-hospital patient monitor alarms on nurses: a qualitative analysis.

Varpio L, Kuziemsky C, MacDonald C, King WJ.

Comput Inform Nurs. 2012 Apr;30(4):210-7. doi: 10.1097/NCN.0b013e31823eb581.

PMID:
22156767
18.

Installation of safety devices reduces the risk of home injury in children.

King WJ.

Evid Based Nurs. 2012 Jan;15(1):13-4. doi: 10.1136/ebn.2011.100151. Epub 2011 Sep 25. No abstract available.

PMID:
21949282
19.

Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease.

Schuler JE, King WJ, Dayneka NL, Rastelli L, Marquis E, Chad Z, Hui C.

Can J Public Health. 2011 May-Jun;102(3):196-9.

PMID:
21714318
20.

A general route for the synthesis of functional, protein-based hydrogel microspheres using tailored protein charge.

King WJ, Toepke MW, Murphy WL.

Chem Commun (Camb). 2011 Jan 7;47(1):526-8. doi: 10.1039/c0cc02716b. Epub 2010 Nov 4.

21.

Facile formation of dynamic hydrogel microspheres for triggered growth factor delivery.

King WJ, Toepke MW, Murphy WL.

Acta Biomater. 2011 Mar;7(3):975-85. doi: 10.1016/j.actbio.2010.10.026. Epub 2010 Oct 26.

22.

Triggered drug release from dynamic microspheres via a protein conformational change.

King WJ, Pytel NJ, Ng K, Murphy WL.

Macromol Biosci. 2010 Jun 11;10(6):580-4. doi: 10.1002/mabi.200900382.

PMID:
20127670
23.

Influence of FGF2 and PEG hydrogel matrix properties on hMSC viability and spreading.

King WJ, Jongpaiboonkit L, Murphy WL.

J Biomed Mater Res A. 2010 Jun 1;93(3):1110-23. doi: 10.1002/jbm.a.32601.

24.

Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays.

Jongpaiboonkit L, King WJ, Murphy WL.

Tissue Eng Part A. 2009 Feb;15(2):343-53. doi: 10.1089/ten.tea.2008.0096.

25.

An adaptable hydrogel array format for 3-dimensional cell culture and analysis.

Jongpaiboonkit L, King WJ, Lyons GE, Paguirigan AL, Warrick JW, Beebe DJ, Murphy WL.

Biomaterials. 2008 Aug;29(23):3346-56. doi: 10.1016/j.biomaterials.2008.04.040. Epub 2008 May 16.

26.

Effect of point of care information on inpatient management of bronchiolitis.

King WJ, Le Saux N, Sampson M, Gaboury I, Norris M, Moher D.

BMC Pediatr. 2007 Jan 24;7:4.

27.

Home safety measures and the risk of unintentional injury among young children: a multicentre case-control study.

LeBlanc JC, Pless IB, King WJ, Bawden H, Bernard-Bonnin AC, Klassen T, Tenenbein M.

CMAJ. 2006 Oct 10;175(8):883-7. Epub 2006 Sep 22.

28.

Should bodychecking be allowed in minor hockey?

King WJ, LeBlanc CM.

CMAJ. 2006 Jul 18;175(2):163. No abstract available.

29.

Long term effects of a home visit to prevent childhood injury: three year follow up of a randomized trial.

King WJ, LeBlanc JC, Barrowman NJ, Klassen TP, Bernard-Bonnin AC, Robitaille Y, Tenenbein M, Pless IB.

Inj Prev. 2005 Apr;11(2):106-9.

30.

Child protection: a neglected area of pediatric residency training.

Ward MG, Bennett S, Plint AC, King WJ, Jabbour M, Gaboury I.

Child Abuse Negl. 2004 Oct;28(10):1113-22.

PMID:
15519439
31.

Prevention of shaken baby syndrome: Never shake a baby.

Ward MG, Bennett S, King WJ.

Paediatr Child Health. 2004 May;9(5):319-21.

32.

The effect of computerized physician order entry on medication errors and adverse drug events in pediatric inpatients.

King WJ, Paice N, Rangrej J, Forestell GJ, Swartz R.

Pediatrics. 2003 Sep;112(3 Pt 1):506-9.

PMID:
12949274
33.

Home injury patterns in children: A comparison by hospital sites.

Bernard-Bonnin AC, Pless IB, Robitaille Y, Leblanc J, King WJ, Tenenbein M, Klassen TP.

Paediatr Child Health. 2003 Sep;8(7):433-7.

34.

Strangulation with intravenous tubing: a previously undescribed adverse advent in children.

Garros D, King WJ, Brady-Fryer B, Klassen TP.

Pediatrics. 2003 Jun;111(6 Pt 1):e732-4.

PMID:
12777593
35.

Shaken baby syndrome in Canada: clinical characteristics and outcomes of hospital cases.

King WJ, MacKay M, Sirnick A; Canadian Shaken Baby Study Group.

CMAJ. 2003 Jan 21;168(2):155-9.

37.

Fipronil: environmental fate, ecotoxicology, and human health concerns.

Tingle CC, Rother JA, Dewhurst CF, Lauer S, King WJ.

Rev Environ Contam Toxicol. 2003;176:1-66. Review.

PMID:
12442503
38.

Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.

Comer RM, King WJ, Ardjomand N, Theoharis S, George AJ, Larkin DF.

Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1095-103. Erratum in: Invest Ophthalmol Vis Sci 2002 Jun;43(6):1701.

PMID:
11923251
39.

Neuronal apoptosis inhibitory protein expression after traumatic brain injury in the mouse.

Hutchison JS, Derrane RE, Johnston DL, Gendron N, Barnes D, Fliss H, King WJ, Rasquinha I, MacManus J, Robertson GS, MacKenzie AE.

J Neurotrauma. 2001 Dec;18(12):1333-47.

PMID:
11780864
40.

The effectiveness of a home visit to prevent childhood injury.

King WJ, Klassen TP, LeBlanc J, Bernard-Bonnin AC, Robitaille Y, Pham B, Coyle D, Tenenbein M, Pless IB.

Pediatrics. 2001 Aug;108(2):382-8.

PMID:
11483803
41.

Transferrin receptor-mediated gene transfer to the corneal endothelium.

Tan PH, King WJ, Chen D, Awad HM, Mackett M, Lechler RI, Larkin DF, George AJ.

Transplantation. 2001 Feb 27;71(4):552-60.

PMID:
11258435
42.

Cytokine and chemokine expression kinetics after corneal transplantation.

King WJ, Comer RM, Hudde T, Larkin DF, George AJ.

Transplantation. 2000 Oct 27;70(8):1225-33.

PMID:
11063345
43.

Gene delivery to the corneal endothelium.

George AJ, Arancibia-Cárcamo CV, Awad HM, Comer RM, Fehevari Z, King WJ, Kadifachi M, Hudde T, Kerouedan-Lebossé C, Mirza F, Barbaros Oral H, Rayner SA, Tan PH, Tay E, Larkin DF.

Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 2):S194-200. Review.

PMID:
11029394
44.

Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation.

Rayner SA, King WJ, Comer RM, Isaacs JD, Hale G, George AJ, Larkin DF.

Clin Exp Immunol. 2000 Oct;122(1):109-16.

45.

The effect of Kawasaki disease on cognition and behavior.

King WJ, Schlieper A, Birdi N, Cappelli M, Korneluk Y, Rowe PC.

Arch Pediatr Adolesc Med. 2000 May;154(5):463-8.

PMID:
10807296
46.

Age-related immunogenicity of meningococcal polysaccharide vaccine in aboriginal children and adolescents living in a Northern Manitoba reserve community.

Law BJ, Rosenberg T, MacDonald NE, Ashton FE, Huang JC, King WJ, Ferris WJ, Gray GJ.

Pediatr Infect Dis J. 1998 Oct;17(10):860-4.

PMID:
9802625
48.

Neisseria meningitidis in the 1990s.

King WJ, MacDonald NE.

Adv Pediatr Infect Dis. 1997;13:143-64. Review. No abstract available.

PMID:
9544311
49.
50.

Supplemental Content

Support Center